Group items tagged

The British Generic Manufacturers Association (BGMA) has elected Diane DiGangi Trench to be its new vice-chair. DiGangi Trench takes up the position replacing Xiromed's Peter Ballard and in 12-months' time will assume the association's chair role from Accord's Peter Kelly. With over 25 years of pharmaceutical industry experience, DiGangi Trench has held a number of senior commercial roles including stints with Takeda and Astra Zeneca. She joined Sandoz in 2018 in the US, where she served as Vice-President, Market Access and Patient Services. In 2021, she became the head of Sandoz' UK business and in her two years in role, she has led the organisation through a post-COVID recovery and growth phase to prepare for the proposed spin out of the company from its parent, Novartis, expected later this year. She said: "It's a great honor to take on the role of Vice Chair of the BGMA. The success of the generics and biosimilar industry is essential to the functioning of the NHS. Generic medicines fill four out of five UK prescriptions and biosimilars enable the NHS to expand access to more patients. I am passionate about increasing the sustainability of our industry so we can continue to play our vital part in the health of the nation." Mark Samuels, BGMA chief executive, said: "We are extremely fortunate to be able to call upon the expertise of Diane who has already added significant value through her role on the BGMA board and leadership of a key strategic committee.

The British Generic Manufacturers Association (BGMA), the representative trade association for off-patent medicines, has established a new Women's Networking Group aimed at fostering learning, networking, and career development opportunities for women in the generic and biosimilar medicines industry. Clara Carter, UK country manager of generics at Accord Healthcare, has been elected as the first chair of the group, and Elaine Holisz, strategic engagement director at Advanz, as its vice chair. Clara expressed her enthusiasm for the initiative, saying, "This is a really important association initiative which will cover a wide range of topics and issues." "At its heart, I want it to be about identifying and nurturing talent and breeding confidence in future industry leaders. We will offer mentoring and speaker opportunities among a wide range of potential activities." With over two decades of experience in the off-patent medicines industry, Clara is committed to providing participants with practical insights and guidance. Diane DiGangi Trench, Country Head UK & Ireland for Sandoz and current chair of the BGMA, highlighted the importance of the initiative, "The Women's Networking Group will be a brilliant platform to encourage new voices in our industry and I am really looking forward to participating in the planned programme."

The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK Country Manager at Viatris, as its new Vice-Chair with immediate effect. He will replace the current chair of the BGMA, Diane DiGangi-Trench, who is the UK country head for Sandoz. Salzman, who is originally from Australia, has served approximately 1 billion patients worldwide last year as the UK Country Manager at Viatris, a global pharmaceutical company operating in 165 countries. In his role as BGMA Vice-Chair, Salzmann would focus on working in partnership with key stakeholders - the NHS, healthcare professionals, policy makers, clinical societies, patient associations, academia - to ensure access to affordable and sustainable medicines for patients and the NHS.